Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS

Published:2016-07-14 Issue:9 Volume:17 Page:925-934
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Zhang Ruohan,Qiao Hongyu,Chen Suning,Chen Xu,Dou Kefeng,Wei Li,Zhang Jian

Funder

National Natural Science Foundation of China (NSFC)

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/15384047.2016.1210728

Reference50 articles.

1. Genomics-Based Prognosis and Therapeutic Prediction in Breast Cancer

2. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

3. Untangling the ErbB signalling network

4. Treatment of HER2-positive breast cancer: current status and future perspectives

5. Lapatinib in the treatment of breast cancer

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine sensitizes immune checkpoint blockade therapy in melanoma by NQO1 inhibition and ROS activation;International Immunopharmacology;2024-12

2. NRF2 inhibitors: Recent progress, future design and therapeutic potential;European Journal of Medicinal Chemistry;2024-12

3. Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease;Current Reviews in Clinical and Experimental Pharmacology;2024-11

4. Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance;Chinese Medicine;2024-08-20

5. Terpene extract from the stem of Celastrus orbiculatus inhibits actin cytoskeleton remodelling in gastric cancer cells by regulating the protein interaction between PTBP1 and ACTN4;Journal of Pharmaceutical Analysis;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3